Vaccine Delivery Devices Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 5.81 Billion |
| Market Size (2029) | USD 8.11 Billion |
| CAGR (2024 - 2029) | 6.89 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Vaccine Delivery Devices Market Analysis
The Global Vaccine Delivery Devices Market size is estimated at USD 5.81 billion in 2024, and is expected to reach USD 8.11 billion by 2029, growing at a CAGR of 6.89% during the forecast period (2024-2029).
The COVID-19 pandemic had a substantial impact on the vaccine delivery device market. Initially, the market was hampered due to limited production and disruption in the supply chain following strict regulations by governments worldwide. However, the market continued to grow during the pandemic's later phases. As COVID-19 infection continued to spread across the communities to a global level vigorously, the demand for an effective vaccine and permanent cure for the disease increased. This further fueled the demand for the availability of novel vaccine delivery devices, hence driving the market's growth.
Additionally, vigorous vaccination campaigns and government initiatives accelerated the availability of vaccine delivery devices globally. For instance, in April 2022, Pan American Health Organization (PAHO) called for a vaccination campaign to close the vaccination gap, including COVID-19 vaccination in the United States. Furthermore, according to a data sheet released by the WHO in November 2022, more than 16 billion vaccine doses worth USD 141,000 million (USD 41 billion) were supplied in 2021, which was almost 03 times higher than the market volume in previous years. This was primarily driven by COVID-19 vaccines. Thus, due to the increasing development of COVID-19 vaccines, the demand for vaccine delivery devices also increased. Thus, owing to the factors above, the COVID-19 pandemic potentially impacted the market studied and is expected to project the market toward growth over the forecast period.
Factors such as growing immunization programs and investment in vaccine research and development in novel drug delivery technologies are anticipated to fuel the segment growth over the forecast period of the study.
Vaccination or immunization is a global health and development program to save millions of lives. Vaccines work with the body's natural defense system to build protection and reduce the risks of getting a disease. With increasing awareness among the target population of improved health, the demand for vaccines and vaccinations is increasing worldwide. For instance, according to UNICEF's data updated in July 2022, along with its partners, UNICEF conducts immunization programs in almost half of the world. In more than 100 countries, UNICEF works with governments, the private sector, non-governmental organizations, and other United Nations (UN) agencies to engage communities, procure and distribute vaccines, and help ensure affordable access for even the hardest-to-reach families. Hence, the rise in activities related to vaccination is predicted to create a demand for the availability of vaccine-delivery devices, thereby garnering the growth of the market studied.
Furthermore, market players are engaged in strategic activities such as mergers and acquisitions and product launches to accelerate the availability of products in the market. For instance, in September 2022, the next-generation glass pre-fillable syringe (PFS) called BD Effivax was introduced by Becton, Dickin, son, and Company. The Company sets a new benchmark for performance for vaccine PFS with new and tighter criteria for processability, cosmetics, contamination, and integrity. In addition, in August 2021, the Drug Controller General of India (DCGI) approved the plasmid DNA Vaccine for COVID-19 called ZyCo, V-D, developed by Zydus Cadila. The vaccines are exclusively administered using the PharmaJet Tropis Needle-free jet Injection System. Thus, the availability of technologically advanced products is anticipated to fuel the market's growth during the forecast period.
Hence, growing immunization programs, investment in vaccine research, and the development of novel drug delivery technologies fuel the vaccine delivery devices market. However, the high cost of microneedles is expected to restrain the vaccine delivery devices market during the analysis period.
Vaccine Delivery Devices Market Trends
This section covers the major market trends shaping the Vaccine Delivery Devices Market according to our research experts:
Syringes are Expected to Occupy a Significant Share in the Vaccine Delivery Devices Market Over the Forecast Period
Syringes are devices used to inject medication into or withdraw fluid from the body. It's most widely used to inject vaccines into the human body. There are different syringe measures according to the intravenous, intramuscular, and intradermal requirements. Being used widely in hospitals and clinics, syringes serve a huge part in the vaccine delivery devices market.
Several benefits associated with syringes increase their adoption for vaccine delivery among end users. According to an article published by the Association of periOperative Registered Nurses (AORN) in April 2021, prefilled syringes are preferred for the delivery of drugs and vaccines owing to various benefits offered in clinical settings such as waste reduction, better storage, and lesser time consumption.
Also, WHO recommends the usage of auto-disable (AD) syringes for the immunization program because they are intended to prevent re-use as AD syringes lock automatically after a single use. Further, AD syringes offer the best guarantee that vaccinations are administered safely and without the chance of infection from contaminated needles. Hence, due to these benefits, the demand for syringes in vaccine delivery is expected to increase, accelerating the segment's growth.
Further, the growing number of immunization programs and easy availability of syringes is expected to play a crucial role in the growth of the syringe segment in the vaccine delivery market. In addition, with the ongoing large-scale vaccination programs worldwide, syringes are being used widely in delivering vaccines, and thus, the production of syringes has increased significantly. For instance, in March 2021, Hindustan Syringes and Medical Devices Ltd (HMD) received orders from the Indian government to supply 256 million auto-disposable syringes, earlier HMD received an order of 177.5 million 0.5 mL auto-disposable syringes from the Indian government in the wake of COVID-19 pandemic. Hence, owing to the aforementioned factors, the syringes segment is expected to occupy a significant share of the vaccine delivery devices market over the forecast period.
North America is Expected Holds a Major Share in the Vaccine Delivery Devices Market Over the Forecast Period
North America is anticipated to hold the major market share of the vaccine delivery devices market over the forecast period. The market growth in North America can be attributed to an increase in vaccine research and development (R&D), as well as the availability of investment and funding opportunities across the countries in the region.
Increased investment in R&D to bring new vaccination technologies to market is also expected to boost the region's market. According to a report published by European Commission in June 2021, the United States holds most of the shares in the research and development of vaccines. As per the news release in May 2022 by the National Institute of Allergy and Infectious Diseases (NIAID), the development of clinical trials shows promising results for a vaccine for a rare deadly mosquito-borne virus. The vaccine is developed by the NIAID Vaccine Research Center (VRC).
In addition, key product innovations, the quick spread of pandemics, increased vaccination awareness, and the presence of manufacturers in the region are factors that are anticipated to contribute to the growth of the vaccine delivery devices market. For instance, as per CDC's update in December 2022, CDC launched the Partnering for Vaccine Equity (P4VE) program and focused on increasing equity in adult immunization. CDC provided more than USD 156 million in funding and support to national, state, local, and community-level partners, who are prioritizing equity in vaccination access and uptake for those groups that experience disparities in immunization.
In addition, in December 2022, the Administration for Community Living (ACL) awarded two grants totaling USD 125 million to rapidly increase vaccination among older adults and people with disabilities to receive the updated COVID-19 vaccine and annual flu vaccine. These programs will distribute funding and leverage partnerships across the aging and disability networks to host community vaccine clinics, provide in-home vaccinations, provide transportation to vaccination sites, conduct outreach and education to older adults and disabled people, and more. Thus, owing to increasing vaccination programs and investments in vaccine research are anticipated to fuel the demand for vaccine delivery devices and garner the studied market growth in North America.
Vaccine Delivery Devices Industry Overview
The vaccine delivery devices market is competitive due to several companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies with significant market shares and is well known. Some of the few market players in the global market include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Gerresheimer AG, and PharmaJet Inc., among others.
Vaccine Delivery Devices Market Leaders
-
Terumo
-
B. Braun Melsungen AG
-
Becton, Dickinson and Company
-
Gerresheimer AG
-
PharmaJet Inc.
*Disclaimer: Major Players sorted in no particular order
Vaccine Delivery Devices Market News
- In December 2022, the Central Drugs Standard Control Organization (CDSCO) of India approved the Bharat Biotech International Limited (BBIL) for nasal COVID-19 vaccine restricted for use in emergencies in the age group of 18 and above.
- In January 2022, Pfizer and Acuitas Therapeutics signed a partnership agreement for a lipid nanoparticle delivery system for mRNA vaccines and therapeutics.
Vaccine Delivery Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Immunization Program and Investment for Vaccine Research
- 4.2.2 Development in Novel Drug Delivery Technologies
-
4.3 Market Restraints
- 4.3.1 High cost for micro needles
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product Type
- 5.1.1 Syringes
- 5.1.2 Jet Injectors
- 5.1.3 Other Product Types
-
5.2 By End-User
- 5.2.1 Hospitals
- 5.2.2 Clinics
- 5.2.3 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Becton, Dickinson and Company
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 Terumo Corporation
- 6.1.4 Zhejiang Longde Pharmaceutical Co., Ltd
- 6.1.5 VAXXAS
- 6.1.6 Hindustan Syringes & Medical Devices Ltd
- 6.1.7 Gerresheimer AG
- 6.1.8 Carl-Zeiss-Stiftung (SCHOTT AG)
- 6.1.9 Enesi Pharma
- 6.1.10 PharmaJet Inc.
- 6.1.11 Mystic Pharmaceuticals Inc
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityVaccine Delivery Devices Industry Segmentation
As per the report's scope, vaccine delivery devices are devices intended to deliver the vaccine, a biological preparation that improves immunity to a particular disease. The Vaccine Delivery Devices Market is Segmented by Product Type (Syringes, Jet Injectors, and Other Product Types), End Users (Hospitals, Clinics, and Other End Users), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Product Type | Syringes | |
| Jet Injectors | ||
| Other Product Types | ||
| By End-User | Hospitals | |
| Clinics | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Vaccine Delivery Devices Market Research FAQs
How big is the Global Vaccine Delivery Devices Market?
The Global Vaccine Delivery Devices Market size is expected to reach USD 5.81 billion in 2024 and grow at a CAGR of 6.89% to reach USD 8.11 billion by 2029.
What is the current Global Vaccine Delivery Devices Market size?
In 2024, the Global Vaccine Delivery Devices Market size is expected to reach USD 5.81 billion.
Who are the key players in Global Vaccine Delivery Devices Market?
Terumo, B. Braun Melsungen AG, Becton, Dickinson and Company, Gerresheimer AG and PharmaJet Inc. are the major companies operating in the Global Vaccine Delivery Devices Market.
Which is the fastest growing region in Global Vaccine Delivery Devices Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Vaccine Delivery Devices Market?
In 2024, the North America accounts for the largest market share in Global Vaccine Delivery Devices Market.
What years does this Global Vaccine Delivery Devices Market cover, and what was the market size in 2023?
In 2023, the Global Vaccine Delivery Devices Market size was estimated at USD 5.44 billion. The report covers the Global Vaccine Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Vaccine Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vaccine Delivery Devices Industry Report
Statistics for the 2024 Vaccine Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Vaccine Delivery Devices analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
